Brief: Adial Pharmaceuticals Files Prospectus Relates To Resale Of Up To 2.36 Mln Shares Of Common Stock
12/04/2024 22:12
April 12 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS- FILES PROSPECTUS RELATES TO RESALE
FROM
TIME TO TIME OF UP TO 2.36 MILLION SHARES OF COMMON STOCK BY
SELLING STOCKHOLDERS
Source text for Eikon: ID:n0001213900-24-032568
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)